GHRP-2 (Growth Hormone Releasing Peptide-2)

GHRP-2 Research Peptide: Current Listings and Evidence

> **Research use only. Not for human or animal use.** GHRP-2 is not FDA-approved for therapeutic use. This page is an educational reference for qualified laboratory researchers and does not provide dosing, clinical, or veterinary guidance.

GHRP-2 (growth hormone-releasing peptide-2, also called pralmorelin in parts of the scientific literature) is a synthetic growth hormone secretagogue studied for its interaction with the growth hormone secretagogue receptor. The current Peptides.SO catalog links this compound to **one in-stock listing from one supplier**, priced at **$49.99** when this page was curated. The source row reports a unit label of “mg,” but the imported catalog does not provide a reliable normalized vial size; researchers should therefore confirm net quantity directly from the listing before making any price-per-mg comparison.

What the published literature establishes

GHRP-2 can provoke growth-hormone release in controlled endocrine testing settings. A retrospective adolescent study reported robust growth-hormone responses during GHRP-2 stimulation testing (PMID 38958228). A separate clinical study evaluated the GHRP-2 test in people with hypothalamic-pituitary disorders and examined both growth-hormone and ACTH responses (PMID 35795807). These studies support its identity as a research secretagogue; they do not establish that unregulated retail material is safe, effective, or suitable for treatment.

Current marketplace snapshot

| Catalog signal | Current value | |---|---:| | In-stock offers | 1 | | Suppliers represented | 1 | | Listed price | $49.99 | | Supplier verification badge | Not present | | Published testing score | 0 | | Structured testing criteria | Not reported |

The only represented supplier is UK SARMs. Peptides.SO currently has no structured COA criteria, testing-score evidence, or verified-supplier badge attached to this row. A listing being present or in stock is not evidence of identity, purity, sterility, or concentration.

How to evaluate a research listing

For laboratory procurement, request a batch-specific certificate of analysis that identifies the tested lot and analytical method. Useful identity and purity evidence may include chromatographic and mass-spectrometric data, accompanied by dates, acceptance criteria, and the name of the laboratory. Confirm that the lot number on the document matches the material supplied. If the intended experiment is sensitive to endotoxin, residual solvent, water content, or counterion state, those attributes require separate methods rather than assumptions based on an HPLC purity percentage.

Because the catalog currently exposes only one offer, there is no meaningful within-product supplier comparison. Researchers can review the broader growth-hormone secretagogue comparison, inspect related GHRP-6 listings, or use the site-wide peptide comparison tool before defining procurement criteria. The peptide calculator is provided for laboratory concentration calculations, not human-use protocols.

GHRP-2 compared with ipamorelin

Both compounds are discussed as growth hormone secretagogues, but they are distinct research molecules and should not be treated as interchangeable. Ipamorelin has been investigated as a ghrelin-receptor agonist in gastrointestinal and nociception models, while GHRP-2 has an established role in endocrine stimulation research. Compare the current ipamorelin marketplace page separately and document the exact compound, salt form, lot, and assay conditions in any reproducibility record.

Frequently asked questions

Is GHRP-2 FDA-approved?

No. GHRP-2 is not FDA-approved for therapeutic use. Material sold through research catalogs should be treated strictly as a laboratory reagent.

Does the lowest listed price indicate the best research material?

No. Price does not demonstrate identity, purity, concentration, or fitness for a specific assay. Batch-linked analytical evidence and suitable quality controls matter more than the sticker price.

Why is no price-per-mg comparison shown?

The imported listing reports a unit label but does not expose a sufficiently reliable normalized quantity for a defensible comparison. Peptides.SO avoids presenting a calculated bargain signal when the denominator is unclear.

Can the cited studies validate a supplier's product?

No. PubMed papers describe particular study materials and experimental conditions. They do not authenticate any current commercial lot or supplier claim.

Research-use boundary

GHRP-2 should be handled only under an institutionally approved research protocol by personnel trained for the relevant laboratory procedures. Nothing on this page is medical advice or a recommendation for human or animal administration.